Table 1 |
||
|
Clinicopathological characteristics of Cohorts I and II |
||
| Cohort I (n = 179) |
Cohort II (n = 564) |
|
|
|
||
| Age (years) |
||
| Median (range) |
65 (35 to 97) |
45 (25 to 57) |
| Tumour size |
||
| ≤ 20 mm |
105 (59) |
208 (37) |
| >20 mm |
74 (41) |
356 (63) |
| Grade |
||
| I |
38 (21) |
58 (10) |
| II |
79 (44) |
222 (40) |
| III |
62 (35) |
234 (42) |
| Missing |
50 (8.9) |
|
| Histological type |
||
| Indeterminate |
3 (2) |
7 (2) |
| Invasive ductal carcinoma |
125 (70) |
411 (73) |
| Invasive lobular carcinoma |
31 (17.3) |
43 (7.6) |
| Tubular |
16 (8.9) |
5 (1) |
| Medullary |
4 (2.2) |
25 (4) |
| Mucinous |
3 (1) |
|
| Missing |
70 (12) |
|
| Nodal status |
||
| Negative |
87 (49) |
160 (28) |
| Positive |
65 (36) |
402 (71) |
| Missing |
27 (15) |
2 (0.3) |
| Oestrogen receptor status |
||
| Positive |
157 (88) |
324 (57) |
| Negative |
22 (12) |
151 (27) |
| Missing |
89 (16) |
|
| Progesterone receptor status |
||
| Positive |
52(29) |
147 (26) |
| Negative |
127 (71) |
312 (55) |
| Missing |
105 (19) |
|
|
|
||
|
Data in parentheses represent percentages unless otherwise stated. |
||
|
Rexhepaj et al. Breast Cancer Research 2008 10:R89 doi:10.1186/bcr2187 |
||
